Skip to main content
Evommune, Inc. logo

Evommune, Inc. — Investor Relations & Filings

Ticker · EVMN ISIN · US30054Y1073 Professional, scientific and technical activities
Filings indexed 40 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country US United States of America
Listing EVMN

About Evommune, Inc.

https://www.evommune.com/

Evommune, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing innovative therapies for immune-mediated chronic inflammatory diseases. The company employs leading-edge science and tissue-based insights to target the root causes and key drivers of inflammation. Evommune is advancing a pipeline of differentiated product candidates, aiming to improve patients' daily lives and prevent the long-term effects of uncontrolled inflammation.

Recent filings

Filing Released Lang Actions
424B3
Regulatory Filings
2026-05-07 English
10-Q
Interim / Quarterly Report
2026-05-07 English
8-K
Regulatory Filings
2026-05-07 English
Regulatory Filings 2026
Regulatory Filings
2026-04-27 English
424B3
Regulatory Filings
2026-04-24 English
ARS
Annual Report
2026-04-21 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.